Point72 Hong Kong LTD Karyopharm Therapeutics Inc. Transaction History

Point72 Hong Kong LTD

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $118,856 - $239,716	28,640 Added 6080.68%	29,111 $131,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $4,651 - $11,317	-787 Reduced 62.56%	471 $3,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $49,578 - $81,932	-9,516 Reduced 88.32%	1,258 $8,000
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $47,944 - $114,527	10,774 New	10,774 $63,000
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $2,424 - $3,321	-299 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $2,945 - $5,289	299 New	299 $3,000
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $19,512 - $23,705	-1,379 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.14 - $19.71 $25,932 - $36,148	-1,834 Reduced 57.08%	1,379 $20,000
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $35,225 - $53,580	2,122 Added 194.5%	3,213 $61,000
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $15,688 - $30,242	1,091 New	1,091 $21,000
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $1,522 - $3,187	-269 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.32 - $6.43 $1,162 - $1,729	269 New	269 $2,000
Q4 2018 Feb 14, 2019	SELL	$8.2 - $16.95 $664 - $1,372	-81 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $408 - $508	-24 Reduced 22.86%	81 $1,000
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $1,260 - $2,087	105 New	105 $2,000
Q1 2018 May 15, 2018	SELL	$9.92 - $17.25 $3,313 - $5,761	-334 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $3,056 - $4,004	334	334 $3,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.